Tools hub
Financial Calculators
Private, in-browser — no account required.
NYSE · Healthcare
$108.33
▼ -$0.4600(-0.42%)4:04 PM ET - vs previous closeiQuote as of Sep 4, 2026, 4:04 PM EDT
NYSE market is closed. Showing the latest available regular-session trade from Sep 4, 2026, 4:04 PM EDT.
Market data source
Evidence
86/100
Strong evidence
Session
-0.42%
vs 108.79 prior close
52-week range
47%
of the 81.97–137.49 range
Consensus target
+11.0%
to 120.2 consensus
TECHi stance
Balanced watch
Model confidence 50/100 · 67/76 inputs
Chart
Latest 1D session
1Y · daily bars · USD · Live $108.33 · 254 pts
Live checkTrade access
Affiliate disclosure: TECHi may earn a commission on links to broker partners. Read more.
Prices update fastest. Fundamentals, analyst data, and news update on their own schedules, so check these timestamps before comparing signals.
Price time means the latest available trade or regular-market close. Other times show when that section was checked or published.
Investor playbook
The current snapshot gives bulls more to work with, but the watch list still controls timing.
Use it for
Entry timing, risk check, and catalyst scan
What has to keep working for US investors to stay interested.
Trend support
+3.0%Current price is above the 200-day average.
Cash yield
3.9%$7.38B free-cash-flow base.
Estimate revisions
+4 net5 EPS estimate increases vs 1 cuts in 30 days.
Catalysts and positioning checks that are not duplicate live-pulse metrics.
Latest catalyst
YahooAbbott (ABT) Exceeds Market Returns: Some Facts to Consider
The playbook is derived from quote, analyst, financial, news, and trend snapshots. It is a research workflow aid, not a buy or sell recommendation.
Upcoming events
ABT reports on Oct 13, 2026 during the BMO session.
Countdown
35 days out
As of Sep 4, 2026, 4:04 PM EDT, Abbott Laboratories (ABT) traded at $108.33, a -0.42% move versus the prior close, ranging between $107.36 and $110.01 intraday, and on volume of 6.88M shares. The stock has traded between $81.97 and $137.49 over the past 52 weeks, carries a market capitalization of $187.45B, trades at 35.06x trailing earnings, and yields 2.3% in dividends. Sell-side analysts rate ABT Buy across 33 ratings and carry an average price target of $120.20 (+10.96% implied versus the last quote). ABT's record close stands at $142.60, set on Dec 27, 2021.
Buy analyst tone. Latest catalyst: Abbott (ABT) Exceeds Market Returns: Some Facts to Consider (Yahoo).
Balanced watch. Risk brake (77/100) is the strongest signal; news sentiment (8/100) is the main constraint. Model confidence is 50/100 — some inputs are unavailable, so treat this as a directional research screen rather than a forecast. Long-term secular context is tracked separately: 10 Years +210.7% total; yesterday -0.4%. Comparable past signals have verified against subsequent prices 14.9% of the time.
Expected-return math is scaled by beta and realized volatility before confidence is applied.
Short-horizon expected moves are volume-weighted so thin moves get less credit than confirmed tape.
Sector momentum is included beside the broader market regime.
| Enterprise value | $214.70B |
| Price / sales | 4.15 |
| Price / book | 3.60 |
| Operating margin | 17.07% |
| Return on assets | 5.68% |
| EPS (TTM) | $3.09 |
| Beta (5Y) | 0.59 |
Benchmark context
Compare against its sector ETF and the broad market.
Help · FAQ
3 answers covering latest price, leadership, and sector context.
TECHi articles and Two Takes linked to ABT. Full feed on the ABT news page.
TECHi displays provider-supplied values only when the corresponding field is present.
TECHi.com